CHOP Hematologist Hails Approval of Two New Drugs To Manage Sickle Cell Disease (SCD)
Published on
The US Food and Drug Administration has granted accelerated approval to two novel drugs to treat sickle cell disease.
Published on
The US Food and Drug Administration has granted accelerated approval to two novel drugs to treat sickle cell disease.
Published on
Stefano Rivella, PhD, an expert in creating the next-generation lentiviral vectors for the cure of hemoglobinopathies including sickle cell disease (SCD), as well as a leader in the discovery of erythroid and iron disorders including beta-thalassemia, has led three new published studies that make significant contributions to the scientific body of literature regarding red blood cells, and how manipulating the production of red cells can lead to the development of new disease-modifying therapies.